The economic burden of heart failure

Clin Cardiol. 2000 Mar;23(3 Suppl):III6-10. doi: 10.1002/clc.4960231503.

Abstract

Heart failure, a major cause of morbidity and mortality among the elderly, is a serious public health problem. As the population ages and the prevalence of heart failure increases, expenditures related to the care of these patients will climb dramatically. As a result, the health care industry must develop strategies to contain this staggering economic burden. Strategies may include adopting approaches for preventing heart failure and implementing new treatment modalities with proven efficacy into large-scale clinical practice. Successful implementation of these strategies will require intensive physician and patient education and development of innovative approaches to fund support services.

MeSH terms

  • Angiotensin-Converting Enzyme Inhibitors / administration & dosage
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Cost of Illness
  • Heart Failure / economics*
  • Heart Failure / mortality
  • Hospitalization / economics
  • Humans
  • Patient Compliance
  • Practice Patterns, Physicians'
  • Survival Rate
  • Ventricular Dysfunction, Left / mortality

Substances

  • Angiotensin-Converting Enzyme Inhibitors